Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "N03AF" (39)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Carbamazepine (N03AF01) 18 products
WHO-DDD
DrugBank.ca
IP
CI
Tegretol 400
200
28.50
47.40
10 %
Tablets: Carbamazepinum 400 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Tegretol CR 200
200
20.33
38.55
10 %
Divitabs: Carbamazepinum 200 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Tegretol CR 400
-
T
200
36.15
55.75
10 %
Divitabs: Carbamazepinum 400 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Tegretol 200
-
T
50 Tablet(s)
4.70
14.30
10 %
Tablets: Carbamazepinum 200 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Tegretol 2%
250 ml
4.45
14.05
10 %
Suspension (oral): Carbamazepinum 100 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Timonil
250 ml
3.78
13.35
10 %
Sirup: Carbamazepinum 100 mg
Desitin Pharma GmbH
B / SL / SG
FB
G
IP
CI
Timonil
50 Tablet(s)
3.58
13.15
10 %
Tablets: Carbamazepinum 200 mg
Desitin Pharma GmbH
B / SL / SG
FB
G
IP
CI
Timonil 200 retard
‐
I
50 Tablet(s)
5.87
15.60
10 %
Delayed release tablets: Carbamazepinum 200 mg
Desitin Pharma GmbH
B / SL
FB
G
IP
CI
Timonil 200 retard
‐
I
200 Tablet(s)
15.49
33.25
10 %
Delayed release tablets: Carbamazepinum 200 mg
Desitin Pharma GmbH
●
B / SL
FB
G
IP
CI
Timonil 300 retard
‐
I
100 Tablet(s)
15.70
33.50
10 %
Delayed release tablets: Carbamazepinum 300 mg
Desitin Pharma GmbH
B / SL
FB
G
IP
CI
Timonil 400 retard
‐
I
100 Tablet(s)
14.45
32.15
10 %
Delayed release tablets: Carbamazepinum 400 mg
Desitin Pharma GmbH
●
B / SL
FB
G
IP
CI
Timonil 600 retard
‐
I
50 Tablet(s)
13.40
31.00
10 %
Delayed release tablets: Carbamazepinum 600 mg
Desitin Pharma GmbH
B / SL
FB
G
IP
CI
Tegretol 400
30 Tablet(s)
4.73
14.40
10 %
Tablets: Carbamazepinum 400 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Tegretol 400
200 Tablet(s)
28.50
47.40
10 %
Tablets: Carbamazepinum 400 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Tegretol CR 200
50 Tablet(s)
5.97
15.75
10 %
Divitabs: Carbamazepinum 200 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Tegretol CR 200
200 Tablet(s)
20.33
38.55
10 %
Divitabs: Carbamazepinum 200 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Tegretol CR 400
-
T
30 Tablet(s)
6.01
15.75
10 %
Divitabs: Carbamazepinum 400 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Tegretol CR 400
-
T
200 Tablet(s)
36.15
55.75
10 %
Divitabs: Carbamazepinum 400 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
Oxcarbazepine (N03AF02) 8 products
WHO-DDD
DrugBank.ca
IP
CI
Trileptal 60 mg/ml
100 ml
12.06
29.55
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Trileptal 60 mg/ml
250 ml
26.96
45.75
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Trileptal 300 mg
50 Tablet(s)
18.24
36.25
10 %
Coated tablets: Oxcarbazepinum 300 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Trileptal 600 mg
50 Tablet(s)
33.69
53.05
10 %
Coated tablets: Oxcarbazepinum 600 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Apydan extent 150 mg
‐
I
50 Tablet(s)
7.02
16.85
10 %
Tablets: Oxcarbazepinum 150 mg
Desitin Pharma GmbH
B / SL
FB
G
IP
CI
Apydan extent 300 mg
‐
I
50 Tablet(s)
13.92
31.55
10 %
Tablets: Oxcarbazepinum 300 mg
Desitin Pharma GmbH
B / SL
FB
G
IP
CI
Apydan extent 600 mg
‐
I
50 Tablet(s)
25.72
44.40
10 %
Tablets: Oxcarbazepinum 600 mg
Desitin Pharma GmbH
B / SL
FB
G
IP
CI
Trileptal 150 mg
50
PR
PR
k.A.
Coated tablets: Oxcarbazepinum 150 mg
Novartis Pharma
Schweiz AG
B
FB
G
Rufinamide (N03AF03) 8 products
WHO-DDD
DrugBank.ca
L
IP
CI
Inovelon 200 mg
60 Tablet(s)
42.05
62.15
10 %
Coated tablets: Rufinamidum 200 mg
Eisai Pharma AG
B / SL
FB
G
L
IP
CI
Inovelon 400 mg
100 Tablet(s)
135.41
163.70
10 %
Coated tablets: Rufinamidum 400 mg
Eisai Pharma AG
B / SL
FB
G
L
IP
CI
Inovelon
460 ml
68.01
90.40
10 %
Suspension (oral): Rufinamidum 40 mg/ml
Eisai Pharma AG
B / SL
FB
G
IP
CI
Inovelon 100 mg
10 Tablet(s)
11.74
25.75
k.A.
Coated tablets: Rufinamidum 100 mg
Eisai Pharma AG
B
FB
G
IP
CI
Inovelon 200 mg
50 Tablet(s)
PR
PR
k.A.
Coated tablets: Rufinamidum 200 mg
Eisai Pharma AG
B
FB
G
IP
CI
Inovelon 400 mg
50 Tablet(s)
PR
PR
k.A.
Coated tablets: Rufinamidum 400 mg
Eisai Pharma AG
B
FB
G
IP
CI
Inovelon 400 mg
60 Tablet(s)
PR
PR
k.A.
Coated tablets: Rufinamidum 400 mg
Eisai Pharma AG
B
FB
G
IP
CI
Inovelon 400 mg
200 Tablet(s)
PR
PR
k.A.
Coated tablets: Rufinamidum 400 mg
Eisai Pharma AG
B
FB
G
Eslicarbazepine (N03AF04) 5 products
WHO-DDD
DrugBank.ca
IP
CI
Zebinix 200 mg
60
41.37
61.40
10 %
Tablets: Eslicarbazepini Acetas 200 mg
Bial SA
B / SL
FB
G
IP
Zebinix 800 mg
30
78.18
101.45
10 %
Tablets: Eslicarbazepini Acetas 800 mg
Bial SA
B / SL
FB
G
IP
Zebinix 800 mg
90
234.54
271.50
10 %
Tablets: Eslicarbazepini Acetas 800 mg
Bial SA
B / SL
FB
G
IP
CI
Zebinix 200 mg
20
PR
PR
k.A.
Tablets: Eslicarbazepini Acetas 200 mg
Bial SA
B
FB
G
IP
Zebinix 800 mg
20
PR
PR
k.A.
Tablets: Eslicarbazepini Acetas 800 mg
Bial SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
